135 related articles for article (PubMed ID: 22200727)
1. Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats.
Zhu P; Lin H; Sun C; Lin F; Yu H; Zhuo X; Zhou C; Deng Z
Mol Med Rep; 2012 Mar; 5(3):655-62. PubMed ID: 22200727
[TBL] [Abstract][Full Text] [Related]
2. [Effects of telmisartan and pyridoxamine on abdominal aorta vascular remodeling in spontaneously hypertensive rats].
Jiang F; Zhu PL; Zheng WP; Yu HZ; Huang F; Lin F; Lin H; Sun CA
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jul; 39(7):658-63. PubMed ID: 22088249
[TBL] [Abstract][Full Text] [Related]
3. [Effect of telmisartan and pyridoxamine on oxidative stress in brain tissue of spontaneously hypertensive rats].
Huang F; Zhu PL; Lin F; Lin H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jul; 28(4):342-5. PubMed ID: 23156732
[TBL] [Abstract][Full Text] [Related]
4. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
Fujita H; Fujishima H; Morii T; Sakamoto T; Komatsu K; Hosoba M; Narita T; Takahashi K; Takahashi T; Yamada Y
Hypertens Res; 2012 Feb; 35(2):213-20. PubMed ID: 22072110
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Inoue H
Protein Pept Lett; 2008; 15(8):850-3. PubMed ID: 18855759
[TBL] [Abstract][Full Text] [Related]
6. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
7. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
Xu L; Liu Y
Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
[TBL] [Abstract][Full Text] [Related]
8. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
Zhang Z; Li Z; Cao K; Fang D; Wang F; Bi G; Yang J; He Y; Wu J; Wei Y; Song X
J Hypertens; 2017 Jul; 35(7):1442-1456. PubMed ID: 28244896
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Sato K; Yamashita T; Kurata T; Lukic V; Fukui Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1554-63. PubMed ID: 24780412
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.
Fukui Y; Yamashita T; Kurata T; Sato K; Lukic V; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1545-53. PubMed ID: 24685992
[TBL] [Abstract][Full Text] [Related]
12. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
El-Mahdy NA; El-Sayad ME; El-Kadem AH
Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
[TBL] [Abstract][Full Text] [Related]
13. Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats.
Yoo SM; Choi SH; Jung MD; Lim SC; Baek SH
Hypertens Res; 2015 Feb; 38(2):106-15. PubMed ID: 25319599
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Ueda S; Nakamura K; Imaizumi T; Takeuchi M; Inoue H
J Int Med Res; 2007; 35(4):482-9. PubMed ID: 17697525
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction.
Chiazza F; Cento AS; Collotta D; Nigro D; Rosa G; Baratta F; Bitonto V; Cutrin JC; Aragno M; Mastrocola R; Collino M
Biomed Res Int; 2017; 2017():2682861. PubMed ID: 29214163
[TBL] [Abstract][Full Text] [Related]
16. Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats.
Wienen W; Schierok HJ
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):123-8. PubMed ID: 11881111
[TBL] [Abstract][Full Text] [Related]
17. Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.
Zhai Y; Yamashita T; Kurata T; Fukui Y; Sato K; Kono S; Liu W; Omote Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2350-61. PubMed ID: 25194744
[TBL] [Abstract][Full Text] [Related]
18. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RAGE by FPS-ZM1 alleviates renal injury in spontaneously hypertensive rats.
Liu Y; Shen W; Chen Q; Cao Q; Di W; Lan R; Chen Z; Bai J; Han Z; Xu W
Eur J Pharmacol; 2020 Sep; 882():173228. PubMed ID: 32502492
[TBL] [Abstract][Full Text] [Related]
20. Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.
Kocak C; Kocak FE; Akcilar R; Bayat Z; Aras B; Metineren MH; Yucel M; Simsek H
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):230-41. PubMed ID: 26515498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
